We demonstrated elevated WEE1 expression and potent cell-killing effects of AZD1775 in NEPC cells and tumor spheroids (Fig. 1), which is consistent with the evidence that WEE1 was previously identified as a potential target for NEPC tumors [6]. The gene discussed is WEE1; the disease is neoplasm.